Sagimet Biosciences Inc. (SGMT) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Sagimet Biosciences Inc. (NASDAQ:SGMT) is held by 70 institutional firms.

• The percentage of Sagimet Biosciences owned by institutions changed from 36.8% in June 2025 to 38.5% in September 2025, marking a slight up trend.
• Quarterly data indicates a 9.52% shift in institutional share volume, and the annual owner count reflects an increase of 12.90%.
• The latest 13F cycle for Sagimet Biosciences reveals that of 70 total investors, 35 funds grew their exposure, whereas 15 reduced theirs and 20 made no changes.
• The aggregate institutional position in Sagimet Biosciences now stands at 12.52Mn shares as of September 2025, after investors increased their holdings (up by 1.09Mn shares quarter on quarter which is down 6.95Mn shares year over year).
• With 1.50Mn shares, Woodline Partners LP commands the largest institutional position in Sagimet Biosciences as of September 30, 2025, equating to 4.62% of the company.
• Among the most significant buyers of Sagimet Biosciences during September 2025 were MILLENNIUM MANAGEMENT LLC (612.94K), D. E. Shaw & Co., Inc. (557.39K), Schonfeld Strategic Advisors LLC (430.64K), Affinity Asset Advisors, LLC (350.00K), RENAISSANCE TECHNOLOGIES LLC (130.50K).
• Leading sellers of Sagimet Biosciences stock in September 2025 included Woodline Partners LP (1.05Mn), UBS Group AG (265.97K), JANE STREET GROUP, LLC (156.45K), BRIDGEWAY CAPITAL MANAGEMENT, LLC (113.20K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (108.85K).
• The top 10 institutional holders of Sagimet Biosciences for the quarter ending September 2025 included Woodline Partners LP (1.50Mn), Blue Owl Capital Holdings LP (1.33Mn), VANGUARD GROUP INC (1.20Mn), BAKER BROS. ADVISORS LP (953.00K), MILLENNIUM MANAGEMENT LLC (776.38K), HHLR ADVISORS, LTD. (724.80K), Siren, L.L.C. (724.77K), D. E. Shaw & Co., Inc. (701.24K), BlackRock, Inc. (612.72K), Schonfeld Strategic Advisors LLC (523.77K).